Heart bypass drug showdown: which pill keeps arteries open longest?
NCT ID NCT04310995
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study compares three common heart medications (nicorandil, diltiazem, and isosorbide mononitrate) to see which best prevents the narrowing or failure of radial artery grafts used in coronary artery bypass surgery. About 150 adults who recently had bypass surgery will take one of the three drugs for 24 weeks, with follow-up imaging and check-ups at 1 week, 24 weeks, and again after 5 years. The goal is to find the most effective anti-spasm treatment to keep grafts open and reduce future heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTISPASTIC THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Shanghai, 200025, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?